Tilray Inc (NASDAQ:TLRY - Get Free Report)'s stock price was down 2.7% during trading on Thursday . The company traded as low as $1.63 and last traded at $1.65. Approximately 4,849,058 shares changed hands during mid-day trading, a decline of 81% from the average daily volume of 24,990,779 shares. The stock had previously closed at $1.69.
Analyst Upgrades and Downgrades
Separately, Roth Mkm cut their price objective on shares of Tilray from $2.00 to $1.75 and set a "neutral" rating for the company in a research report on Friday, October 11th.
Read Our Latest Research Report on Tilray
Tilray Price Performance
The company has a current ratio of 2.47, a quick ratio of 1.57 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $1.27 billion, a PE ratio of -3.74 and a beta of 2.13. The stock's 50-day moving average is $1.70 and its two-hundred day moving average is $1.79.
Tilray (NASDAQ:TLRY - Get Free Report) last released its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.04). Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The firm had revenue of $200.00 million for the quarter, compared to the consensus estimate of $218.70 million. During the same period last year, the firm earned ($0.10) earnings per share. The company's quarterly revenue was up 13.0% on a year-over-year basis. On average, equities analysts predict that Tilray Inc will post -0.14 EPS for the current year.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Prospect Financial Services LLC purchased a new position in Tilray during the second quarter worth about $26,000. Signature Estate & Investment Advisors LLC acquired a new position in Tilray during the 2nd quarter worth approximately $29,000. Jeppson Wealth Management LLC purchased a new position in shares of Tilray in the 2nd quarter valued at $33,000. Vanguard Capital Wealth Advisors acquired a new stake in Tilray during the 2nd quarter worth $34,000. Finally, HBK Sorce Advisory LLC acquired a new stake in Tilray during the 1st quarter worth $37,000. Hedge funds and other institutional investors own 9.35% of the company's stock.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Read More
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
